| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kalvista Pharmaceuticals, Inc. (KALV) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. KALV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 462.6K | $12.49M | - | |
| Other | 223.5K | $6.03M | - | |
| Other | 142.5K | $3.85M | - | |
| Other | 100.0K | $2.70M | - | |
| Other | 51.4K | $1.39M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2025 | Palleiko Benjamin L46 | Chief Executive Officer | Sale+OE | 10,940 | $13.22 | $144,657.43 | -2.8% | -2.9% | - | |
| Aug 22, 2025 | Audhya Paul K. | Chief Medical Officer | Sale+OE | 2,942 | $13.22 | $38,901.48 | -2.4% | -2.9% | - | |
| Aug 18, 2025 | Audhya Paul K. | Chief Medical Officer | Sale+OE | 2,939 | $13.19 | $38,756.59 | -2.5% | +11.4% | - | |
| Aug 18, 2025 | Palleiko Benjamin L46 | Chief Executive Officer | Sale+OE | 4,409 | $13.19 | $58,141.48 | -1.2% | +11.4% | - | |
| Aug 18, 2025 | Yea Christopher53 | Chief Development Officer | Sale+OE | 2,649 | $13.19 | $34,932.36 | -2.0% | +11.4% | - | |
| Jul 9, 2025 | Palleiko Benjamin L46 | Chief Executive Officer | Sell | 32,979 | $15.69 | $517,522.96 | -8.2% | -31.7% | - | |
| Jul 9, 2025 | Yea Christopher53 | Chief Development Officer | Sell | 30,250 | $15.69 | $474,698.13 | -19.1% | -31.7% | - | |
| Jun 9, 2025 | Palleiko Benjamin L46 | Chief Executive Officer | Sale+OE | 7,169 | $14.50 | $103,950.50 | -2.2% | +8.1% | +82.9% | |
| May 23, 2025 | Audhya Paul K. | Chief Medical Officer | Sale+OE | 2,146 | $11.31 | $24,271.69 | -1.9% | +13.0% | +133.6% | |
| May 23, 2025 | Yea Christopher53 | Chief Development Officer | Sale+OE | 1,926 | $11.31 | $21,781.71 | -1.9% | +13.0% | +133.6% |